Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
Chris Coleman said the full-back "did not want to play international football" after naming his squad for next month's World Cup qualifier.
Well it wouldn't be a Bank Holiday weekend without a drop of rain! With some sunshine thrown in!
The UEFA Champions Festival in Cardiff Bay will be the main fanzone for the UEFA Champions League Final in the host city.